OncoCyte Operating Cash Flow Per Share 2014-2024 | OCX

OncoCyte operating cash flow per share from 2014 to 2024. Operating cash flow per share can be defined as a measure of financial performance calculated as operating cash flow, expressed on a per share basis
Sector Industry Market Cap Revenue
Medical Medical Services $0.089B $0.002B
OncoCyte Corporation is primarily focused on the development of novel, non-invasive blood and urine diagnostic tests for detection of cancer. OncoCyte Corporation is based in Alameda, California.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $142.368B 26.70
Elevance Health (ELV) United States $93.458B 12.06
CVS Health (CVS) United States $81.990B 12.00
Cencora (COR) United States $56.269B 20.42
Natera (NTRA) United States $20.939B 0.00
DiDi Global (DIDIY) China $20.365B 29.93
BioMerieux (BMXMF) France $15.507B 0.00
ICON (ICLR) Ireland $12.058B 10.95
EUROFINS SCIENT (ERFSF) Luxembourg $11.881B 0.00
Solventum (SOLV) United States $11.461B 10.69
CochLear (CHEOY) Australia $11.380B 0.00
Revvity (RVTY) United States $11.373B 19.20
Doximity (DOCS) United States $10.781B 56.07
Viatris (VTRS) United States $9.955B 3.15
Medpace Holdings (MEDP) United States $8.805B 23.39
Avantor (AVTR) United States $8.647B 12.56
Sonic Healthcare (SKHHY) Australia $8.152B 0.00
HealthEquity (HQY) United States $7.475B 36.77
Charles River Laboratories (CRL) United States $5.761B 11.36
Bausch + Lomb (BLCO) Canada $4.848B 22.13
Amplifon S.p.A (AMFPF) Italy $4.285B 22.62
Alignment Healthcare (ALHC) United States $3.446B 0.00
Organon (OGN) United States $3.421B 3.45
GeneDx Holdings (WGS) United States $3.283B 389.90
Sotera Health (SHC) United States $3.210B 18.54
BrightSpring Health Services (BTSG) United States $3.069B 31.87
Surgery Partners (SGRY) United States $2.863B 32.84
Concentras Parent (CON) United States $2.815B 14.64
Progyny (PGNY) United States $1.967B 43.32
Premier (PINC) United States $1.862B 11.92
Ardent Health Partners (ARDT) United States $1.806B 0.00
GoodRx Holdings (GDRX) United States $1.788B 38.83
Agilon Health (AGL) United States $1.569B 0.00
PACS (PACS) United States $1.486B 0.00
Teladoc Health (TDOC) United States $1.285B 0.00
Pediatrix Medical (MD) United States $1.078B 9.04
Ryman Healthcare (RYHTY) New Zealand $1.039B 0.00
CareDx (CDNA) United States $1.008B 17.10
Establishment Labs Holdings (ESTA) $0.873B 0.00
AMN Healthcare Services Inc (AMN) United States $0.770B 6.09
Embecta (EMBC) United States $0.730B 5.00
Nutex Health (NUTX) United States $0.579B 11.35
QDM (QDMI) Hong Kong, SAR China $0.554B 0.00
Auna S.A (AUNA) Luxembourg $0.530B 14.04
Sonida Senior Living (SNDA) United States $0.444B 0.00
InnovAge Holding (INNV) United States $0.412B 0.00
Enhabit (EHAB) United States $0.402B 37.90
LifeMD (LFMD) United States $0.384B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.349B 0.00
SBC Medicals (SBC) United States $0.347B 0.00
DocGo (DCGO) United States $0.233B 9.50
Oncology Institute (TOI) United States $0.189B 0.00
Performant Healthcare (PHLT) United States $0.184B 0.00
Beauty Health (SKIN) United States $0.125B 0.00
Sera Prognostics (SERA) United States $0.112B 0.00
Ascend Wellness Holdings (AAWH) United States $0.084B 0.00
So-Young (SY) China $0.084B 0.00
Biodesix (BDSX) United States $0.078B 0.00
Basel Medical Group (BMGL) Singapore $0.077B 0.00
IceCure Medical (ICCM) Israel $0.070B 0.00
NeueHealth (NEUE) United States $0.057B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.029B 0.00
Pheton Holdings (PTHL) China $0.021B 0.00
ModivCare (MODV) United States $0.018B 6.32
SeaStar Medical Holding (ICU) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.012B 0.00
KindlyMD (KDLY) United States $0.011B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.004B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00